|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02252 MEDBOT-B
Nominal 
9.100 +0.170 (+1.904%) | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | (567,843) | (898,475) | (540,486) | (103,042) |
| Net Cash from / (used in) Investing Activities | -- | (58,385) | (267,825) | (396,575) | (15,008) |
| Net Cash from / (used in) Financing Activities | -- | 385,676 | (27,946) | 1,392,245 | 1,560,668 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (240,552) | (1,194,246) | 455,184 | 1,442,618 |
| Cash & Cash Equivalents at beginning of period | -- | 747,962 | 1,940,825 | 1,497,326 | 54,708 |
| Effect of Foreign Exchange Rate Changes | -- | 301 | 1,383 | (11,685) | 0 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 507,711 | 747,962 | 1,940,825 | 1,497,326 |
| Remarks: | Real time quote last updated: 15/11/2024 11:56 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -277,161,000 |
| %Change | -48.580% |
| EPS / (LPS) | RMB -0.290 |
| NBV Per Share (¥) | RMB 0.287 |